 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 March 1996 | Volume 124 Issue 5 | Pages 485-489
Objective: To compare the quality, relevance, and structure of drug studies published in symposium proceedings that are sponsored by drug companies with 1) articles from symposia with other sponsors and 2) articles in the peer-reviewed parent journals of symposium proceedings; and to study the relation between drug company sponsorship and study outcome.
Design: Cross-sectional studies of clinical drug studies published in symposium proceedings or their parent medical journals.
Measurements: The proportion of articles with no methods sections (which are necessary to assess quality); methodologic quality and clinical relevance scores; and the proportion of articles with outcomes favoring the drug of interest.
Results: Symposia sponsored by single drug companies had more articles without methods sections (10%; 108 of 1064) than did symposia that had other sponsors (3%; 58 of 2314) or symposia that had no mentioned sponsor (2%; 29 of 1663) (P < 0.001). The mean methodologic quality and relevance scores of articles were similar both by type of sponsorship and between articles published in symposia sponsored by single drug companies and articles from the parent journals. Significantly more articles with drug company support (98%; 39 of 40) than without drug company support (79%; 89 of 112) had outcomes favoring the drug of interest (P = 0.01).
Conclusions: Articles in symposia sponsored by single drug companies were similar in quality and clinical relevance to articles with other sponsors and to articles published in the parent journals. Articles with drug company support are more likely than articles without drug company support to have outcomes favoring the drug of interest.
Author and Article Information
From the University of Pennsylvania, Philadelphia, Pennsylvania; and the University of California, San Francisco, California.
ARTICLE
The Quality of Drug Studies Published in Symposium Proceedings
Acknowledgments: The authors thank their reviewers Anu Banerjee, MD, Steve Deputy, MD, Piero Gepetti, MD, Saba Masho, MD, MPH, Haim Mayan, MD, Barry Rotman, MD, Daniel Stryer, MD, and Leah Vaughan, MD, MPH, for their time and effort.
Grant Support: In part by the American Association for Retired Persons, the Cigarette and Tobacco Surtax Fund of the State of California through the Tobacco-Related Disease Research Program of the University of California (award 4RT0035), the Pew Charitable Trusts, and the Veterans Affairs Office of Academic Affairs and Health Services Research and Development Service Research Funds.
Requests for Reprints: Mildred K. Cho, PhD, University of Pennsylvania Center for Bioethics, 3401 Market Street, Suite 320, Philadelphia, PA 19104-3308.
Current Author Addresses: Dr. Cho: University of Pennsylvania Center for Bioethics, 3401 Market Street, Suite 320, Philadelphia, PA 19104-3308.
This article has been cited by other articles:
|
|
 |
|
  N. Pannu, S. Klarenbach, N. Wiebe, B. Manns, M. Tonelli, and for the Alberta Kidney Disease Network Renal Replacement Therapy in Patients With Acute Renal Failure: A Systematic Review JAMA, February 20, 2008; 299(7): 793 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Yank, D. Rennie, and L. A Bero Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study BMJ, December 8, 2007; 335(7631): 1202 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nieto, A. Mazon, R. Pamies, J. J. Linana, A. Lanuza, F. O. Jimenez, A. Medina-Hernandez, and F. J. Nieto Adverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies Arch Intern Med, October 22, 2007; 167(19): 2047 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tonelli, N. Wiebe, B. Culleton, H. Lee, S. Klarenbach, F. Shrive, B. Manns, and for the Alberta Kidney Disease Network Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2856 - 2866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Reed, D. A. Cook, T. J. Beckman, R. B. Levine, D. E. Kern, and S. M. Wright Association Between Funding and Quality of Published Medical Education Research JAMA, September 5, 2007; 298(9): 1002 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Wick, M Egger, S Trelle, P Juni, and M. Fey The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry Ann. Onc., September 1, 2007; 18(9): 1580 - 1582. [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Hampson, S. Joffe, R. Fowler, J. Verter, and E. J. Emanuel Frequency, Type, and Monetary Value of Financial Conflicts of Interest in Cancer Clinical Research J. Clin. Oncol., August 20, 2007; 25(24): 3609 - 3614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Gray, F. J. Hlubocky, M. J. Ratain, and C. K. Daugherty Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials J. Clin. Oncol., August 10, 2007; 25(23): 3488 - 3494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hall, C. de Antueno, and A. Webber Publication bias in the medical literature: a review by a Canadian Research Ethics Board: [Biais de publication dans la litterature medicale : un compte rendu d'un Comite d'ethique de recherche canadien] Can J Anesth, May 1, 2007; 54(5): 380 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lexchin and D. W Light Commercial influence and the content of medical journals. BMJ, June 17, 2006; 332(7555): 1444 - 1447. [Full Text] [PDF]
|
|
|
|
|
|
F. S. Sierles, A. C. Brodkey, L. M. Cleary, F. A. McCurdy, M. Mintz, J. Frank, D. J. Lynn, J. Chao, B. Z. Morgenstern, W. Shore, et al. Medical Students' Exposure to and Attitudes About Drug Company Interactions: A National Survey JAMA, September 7, 2005; 294(9): 1034 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Brodkey The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem Acad Psychiatry, June 1, 2005; 29(2): 222 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Glantz Tobacco Money at the University of California Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1067 - 1069. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Beecher, E. Harrison, N. Goldstein, M. McDaniel, P. Field, and L. Susskind Risk Perception, Risk Communication, and Stakeholder Involvement for Biosolids Management and Research J. Environ. Qual., January 1, 2005; 34(1): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bhandari, J. W. Busse, D. Jackowski, V. M. Montori, H. Schunemann, S. Sprague, D. Mears, E. H. Schemitsch, D. Heels-Ansdell, and P.J. Devereaux Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials Can. Med. Assoc. J., February 17, 2004; 170(4): 477 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hirsch Randomized clinical trials: What gets published, and when? Can. Med. Assoc. J., February 17, 2004; 170(4): 481 - 483. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Chopra Industry Funding of Clinical Trials: Benefit or Bias? JAMA, July 2, 2003; 290(1): 113 - 114. [Full Text] [PDF]
|
|
|
|
|
|
J. Lexchin, L. A Bero, B. Djulbegovic, and O. Clark Pharmaceutical industry sponsorship and research outcome and quality: systematic review BMJ, May 29, 2003; 326(7400): 1167 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Smith Medical journals and pharmaceutical companies: uneasy bedfellows BMJ, May 29, 2003; 326(7400): 1202 - 1205. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Tobin Conflicts of Interest and AJRCCM: Restating Policy and a New Form to Upload Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1161 - 1164. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Levine, J. D. Gussow, D. Hastings, and A. Eccher Authors' Financial Relationships With the Food and Beverage Industry and Their Published Positions on the Fat Substitute Olestra Am J Public Health, April 1, 2003; 93(4): 664 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Bekelman, Y. Li, and C. P. Gross Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review JAMA, January 22, 2003; 289(4): 454 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Barnes and P. S. Florencio Financial Conflicts of Interest in Human Subjects Research: The Problem of Institutional Conflicts J. Law Med. Ethics, September 1, 2002; 30(3): 390 - 402. [PDF]
|
|
|
|
|
|
P. A. Rochon, L. A. Bero, A. M. Bay, J. L. Gold, J. M. Dergal, M. A. Binns, D. L. Streiner, and J. H. Gurwitz Comparison of Review Articles Published in Peer-Reviewed and Throwaway Journals JAMA, June 5, 2002; 287(21): 2853 - 2856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. HIERHOLZER Buproprion and Sexual Dysfunction Am J Psychiatry, April 1, 2002; 159(4): 677 - 677. [Full Text] [PDF]
|
|
|
|
|
|
C. Ripamonti, C. Sweeney, and E. Bruera Use of Trade Names of Drugs and the Scientific Content of Medical Congresses J. Clin. Oncol., March 15, 2002; 20(6): 1707 - 1708. [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Coyle and for the Ethics and Human Rights Committee, America Physician-Industry Relations. Part 1: Individual Physicians Ann Intern Med, March 5, 2002; 136(5): 396 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yaphe, R. Edman, B. Knishkowy, and J. Herman The association between funding by commercial interests and study outcome in randomized controlled drug trials Fam. Pract., December 1, 2001; 18(6): 565 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A Bero, T. Montini, K. Bryan-Jones, and C. Mangurian Science in regulatory policy making: case studies in the development of workplace smoking restrictions Tob. Control, December 1, 2001; 10(4): 329 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Varkey Time for Introspection Chest, April 1, 2001; 119(4): 1255 - 1256. [Full Text] [PDF]
|
|
|
|
|
|
M. K. Cho, R. Shohara, A. Schissel, and D. Rennie Policies on Faculty Conflicts of Interest at US Universities JAMA, November 1, 2000; 284(17): 2203 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Boyd and L. A. Bero Assessing Faculty Financial Relationships With Industry: A Case Study JAMA, November 1, 2000; 284(17): 2209 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. DeAngelis Conflict of Interest and the Public Trust JAMA, November 1, 2000; 284(17): 2237 - 2238. [Full Text] [PDF]
|
|
|
|
|
|
F. Godlee WHO faces up to its tobacco links BMJ, August 5, 2000; 321(7257): 314 - 315. [Full Text]
|
|
|
|
 |
|
 R. Moynihan, L. Bero, D. Ross-Degnan, D. Henry, K. Lee, J. Watkins, C. Mah, and S. B. Soumerai Coverage by the News Media of the Benefits and Risks of Medications N. Engl. J. Med., June 1, 2000; 342(22): 1645 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bodenheimer Uneasy Alliance -- Clinical Investigators and the Pharmaceutical Industry N. Engl. J. Med., May 18, 2000; 342(20): 1539 - 1544. [Full Text] [PDF]
|
|
|
|
|
|
A. Wazana Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift? JAMA, January 19, 2000; 283(3): 373 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Dorman, C. Counsell, and P. Sandercock Reports of Randomized Trials in Acute Stroke, 1955 to 1995 : What Proportions Were Commercially Sponsored? Stroke, October 1, 1999; 30(10): 1995 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A Bero Accepting commercial sponsorship BMJ, September 11, 1999; 319(7211): 653 - 654. [Full Text]
|
|
|
|
|
|
M. Ausejo, A. Saenz, B. Pham, J. D Kellner, D. W Johnson, D. Moher, and T. P Klassen The effectiveness of glucocorticoids in treating croup: meta-analysis BMJ, September 4, 1999; 319(7210): 595 - 600. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Heck, K. J. Gorelick, L. A. Bero, and D. Barnes Industry Affiliations and Scientific Conclusions JAMA, October 7, 1998; 280(13): 1141 - 1142. [Full Text] [PDF]
|
|
|
|
|
|
R. Smith Beyond conflict of interest BMJ, August 1, 1998; 317(7154): 291 - 292. [Full Text]
|
|
|
|
 |
|
 A. R. Jadad, D. Moher, and T. P. Klassen Guides for Reading and Interpreting Systematic Reviews: II. How Did the Authors Find the Studies and Assess Their Quality? Arch Pediatr Adolesc Med, August 1, 1998; 152(8): 812 - 817. [Full Text] [PDF]
|
|
|
|
|
|
D P Kernick Personal paper: Has health economics lost its way? BMJ, July 18, 1998; 317(7152): 197 - 199. [Full Text]
|
|
|
|
|
|
D. E. Barnes and L. A. Bero Why Review Articles on the Health Effects of Passive Smoking Reach Different Conclusions JAMA, May 20, 1998; 279(19): 1566 - 1570. [Abstract] [Full Text] [PDF]
|
|
Article
